Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sci Pharmtech's share price for the quarter that ended in Dec. 2025 was NT$48.7. Sci Pharmtech's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 120 Mil. Therefore, Sci Pharmtech's market cap for the quarter that ended in Dec. 2025 was NT$5,820 Mil.
Sci Pharmtech's quarterly market cap
declined
from Jun. 2025 (NT$7,732 Mil) to Sep. 2025 (NT$7,171 Mil) and
declined
from Sep. 2025 (NT$7,171 Mil) to Dec. 2025 (NT$5,820 Mil).
Sci Pharmtech's annual market cap
declined
from Dec. 2023 (NT$11,568 Mil) to Dec. 2024 (NT$10,828 Mil) and
declined
from Dec. 2024 (NT$10,828 Mil) to Dec. 2025 (NT$5,820 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sci Pharmtech's Enterprise Value for Today is NT$6,266 Mil.
Sci Pharmtech (TPE:4119) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sci Pharmtech Market Cap Related Terms
Sci Pharmtech Market Cap Historical Data
* Premium members only.
The historical data trend for Sci Pharmtech's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sci Pharmtech Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's Market Cap distribution charts can be found below:
* The bar in red indicates where Sci Pharmtech's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sci Pharmtech's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sci Pharmtech (TPE:4119) has a Market Cap of NT$5,354 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sci Pharmtech and its competitors. According to the industry distribution chart, Sci Pharmtech ranks #545 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 53.4%.
Is Sci Pharmtech's Market Cap too high?
Sci Pharmtech's current Market Cap is NT$5,354 Mil. Based on the distribution chart, Sci Pharmtech ranks #545 out of 1020 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sci Pharmtech ranks #545 out of 1020 companies for Market Cap. This places Sci Pharmtech in the lower half of its industry. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sci Pharmtech and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sci Pharmtech's current Market Cap is NT$5,354 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.43, compared to a current price of NT$44.80 — trading 53.5% below its estimated fair value. The current Market Cap is NT$5,354 Mil. Sci Pharmtech's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current Market Cap is NT$5,354 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sci Pharmtech (TPE:4119) Overvalued in 2026?
Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued.
The current stock price of NT$44.80 is trading 53.5% below its estimated GF Value™ of NT$96.43.
GuruFocus considers Sci Pharmtech to be Possible Value Trap.
Key valuation signals for TPE:4119:
Market Cap: NT$5,354 Mil
GF Value™: NT$96.43 vs. price of NT$44.80 (53.5% below fair value)
No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score
Get the complete analysis for TPE:4119
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4119 has been successfully added to your 
